No CVD Issues Apparent Years After Aromatase Inhibitor Therapy
The findings in breast cancer survivors are 'reassuring,' given the benefit of aromatase inhibitors, the authors say. The study was published as a preprint and has not yet been peer reviewed.
First Look
source https://www.medscape.com/viewarticle/975262?src=rss
First Look
source https://www.medscape.com/viewarticle/975262?src=rss
Comments
Post a Comment